Evaluating drug treatments for Parkinson's disease: how good are the trials?

BMJ. 2002 Jun 22;324(7352):1508-11. doi: 10.1136/bmj.324.7352.1508.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Catechol O-Methyltransferase / therapeutic use
  • Dopamine Agonists / therapeutic use
  • Follow-Up Studies
  • Humans
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Parkinson Disease / drug therapy*
  • Randomized Controlled Trials as Topic / standards*
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Monoamine Oxidase Inhibitors
  • Catechol O-Methyltransferase